diethylnitrosamine has been researched along with calcitriol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Iwata, H; Morii, H; Nishisawa, Y; Otoshi, T; Takada, N | 1 |
| Basak, R; Basu, M; Chatterjee, M | 1 |
| Basak, R; Chatterjee, M; Saha, BK | 1 |
| Basak, R; Chatterjee, M | 1 |
| Basak, R; Bhattacharya, R; Chatterjee, M | 1 |
| Bhattacharya, R; Chatterjee, M; Saha, BK | 1 |
6 other study(ies) available for diethylnitrosamine and calcitriol
| Article | Year |
|---|---|
22-Oxa-1,25(OH)2vitamin D3, a synthetic analogue of vitamin D3, has no promoting activity in a rat liver medium-term bioassay.
Topics: Animals; Antineoplastic Agents; Calcitriol; Carcinogens; Diethylnitrosamine; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Phenobarbital; Rats; Rats, Inbred F344; Time Factors | 1994 |
Combined supplementation of vanadium and 1alpha,25-dihydroxyvitamin D(3) inhibit diethylnitrosamine-induced rat liver carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Calcitriol; Carcinogens; Cytochrome P-450 Enzyme System; Cytosol; Dietary Supplements; Diethylnitrosamine; Drinking; Drug Synergism; Eating; Enzyme Induction; gamma-Glutamyltransferase; Glutathione; Glutathione Transferase; Liver; Liver Neoplasms, Experimental; Male; Microsomes, Liver; Organ Size; Rats; Rats, Sprague-Dawley; Vanadium | 2000 |
Inhibition of diethylnitrosamine-induced rat liver chromosomal aberrations and DNA-strand breaks by synergistic supplementation of vanadium and 1alpha,25-dihydroxyvitamin D(3).
Topics: Animals; Antineoplastic Agents; Calcitriol; Chromosome Aberrations; Diethylnitrosamine; DNA Damage; Drug Synergism; Liver; Liver Neoplasms, Experimental; Male; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Vanadium | 2000 |
Combined supplementation of vanadium and 1alpha,25-dihydroxyvitamin D3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis.
Topics: Administration, Oral; Animals; Body Weight; Calcitriol; Carcinogens; Diethylnitrosamine; Drug Interactions; Glutathione Transferase; Hepatectomy; Hepatocytes; Liver Neoplasms; Male; Neoplasms, Experimental; Phenobarbital; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Vanadium; Water Supply | 2000 |
1 alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes in diethylnitrosamine-initiated and phenobarbital promoted rat hepatocarcinogenesis.
Topics: Animals; Calcitriol; Cytochrome P-450 Enzyme System; Diethylnitrosamine; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Liver; Liver Neoplasms; Male; Microscopy, Electron; Phenobarbital; Rats; Rats, Sprague-Dawley; Time Factors | 2001 |
1alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes and the development of gamma-glutamyltranspeptidase-positive foci in diethylnitrosamine-initiated and streptozotocin-induced diabetes-promoted hepatocarcinogenesis.
Topics: Animals; Body Weight; Calcitriol; Cytoplasm; Diabetes Mellitus, Experimental; Diethylnitrosamine; Endoplasmic Reticulum; gamma-Glutamyltransferase; Glycogen; Hepatocytes; Liver; Liver Neoplasms; Male; Microscopy, Electron; Models, Genetic; Organ Size; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors | 2002 |